Secondary erythrocytosis was seen in cyanotic congenital heart diseases due to low arterial oxygen saturation. This situation allows blood viscoelasticity to increase. Iron deficiency was observed in more than one third of patients with cyanotic congenital heart disease. Microcytosis caused by iron deficiency, though, increases viscoelasticity and thrombosis. Replacement of iron deficiency is frequently recommended in medical monitorings of patients with cyanotic congenital heart diseases. Nonetheless, while iron treatment restores microcytosis, it also increases hemoglobin level. Escalated hemoglobin and hematocrit values cause viscoelasticity to heighten. Given vicious cycle developed, advantage-disadvantage relation of iron treatment applied to cyanotic patients is unclear.
between groups. No difference was established with respect to demographical features between groups with iron deficiency and non iron deficiency.
Average Hb, Hct values were measured respectively as : 14.8 ± 2.4 gr/dl and 45.8 ± 7.5% in the group with iron deficiency; 16.5 ± 2.5 gr/dl and 49.2 ± 8.3% in the group with non iron deficiency (Table 1) . Other hematological parameters between groups with iron deficiency and non iron deficiency were shown in Table 2 .
Initial hematologic values and those after three months were compared in patients who had been applied iron treatment. It was established that Hb value increased approximately from 14.8 ± 2.4 gr/dl to 16.0 ± 2.0'a(p=0.003) three months later. Although there was an increase in hemoglobin and hematocrit values, viscosity value was approximately 5.6 ± 1.0 c poise initially, however, it was determined as 5.5 ± 1.0 c poise after three-month iron treatment (p=0.741). In addition, initial average oxygen saturation increased from 71.7 ± 6.8% to 75.0 ± 6.8% in the group that iron treatment had been applied; this increase was found statistically significant (p<0.001) ( Table 2) .
CONCLUSİONS
Iron deficiency is a frequently seen condition in patients with cyanotic congenital heart disease. Results obtained from the study indicated that iron treatment increased Hb and Hct levels without elevating viscosity in patients with cyanotic congenital heart disease and it caused improvement in clinical symptoms. 
